mechanism of glp-1 receptor agonists Glucagon-like peptide 1 agonists: cardiovascular benefits and mechanisms action The Impact of GLP-1 Receptor
Description
While 1544% of patients experience gastrointestinal symptoms like nausea, these typically represent expected pharmacologic effects rather than true gastroparesis, which requires objective confirmation through gastric emptying studies

Dysesthesia, an abnormal sensation often described as tingling, burning, or numbness in the skin, appeared in 8.8% of participants on the 9 mg dose and 20.9% on the 12 mg dose, compared to just 0.7% on placebo

Ongoing research hints at benefits for cognitive health, particularly in neurodegenerative diseases like Alzheimers, as GLP-1 has anti-inflammatory and neuroprotective properties, Dr

With ongoing research and advancements, retatrutide provides hope for individuals seeking effective management of the comorbidities associated with obesity

Since the medication also contributes to weight loss, both drugs were later released as Wegovy and Zepbound to help people with obesity
